2013
DOI: 10.1001/2013.jamasurg.25
|View full text |Cite
|
Sign up to set email alerts
|

Kidney Transplant Chains Amplify Benefit of Nondirected Donors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
35
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 51 publications
(37 citation statements)
references
References 18 publications
0
35
0
Order By: Relevance
“…4 All participants should consider options that may translate into greater graft longevity or KLYs. There are at least 8 reasons why a participant (either compatible or incompatible) may choose to enroll in KPD with the goal of “trading-up” for a better outcome through donor optimization (measured in KLYs) among other reasons, listed as follows: (1) transplants may last longer (ie, higher expected KLYs) with better donor selection; (2) recipients may require less immunosuppression with better matching, and therefore experience less side effects from medication; (3) recipients may experience less morbidity/mortality by seeking a better match, especially in cases where aggressive desensitization can be avoided entirely 16-18 ; (4) recipients will be easier to transplant in the future (either with a living, or deceased donor) should they require it, because they will be sensitized to fewer antigens (DSA) 20 ; (5) participants help others while at the same time helping the intended recipient who faces the possibility of a repeat transplant if a graft fails—this not only by offloading competition on the waitlist by enabling more transplants per unit time, but also by facilitating more difficult to accomplish transplants in sensitized cohorts of recipients of which the intended recipient may become a member (by developing DSA) should they require a repeat transplant in the future, these concepts being supported by the mathematics driving KPD 3,4,20,21 (6) donor-recipient anatomic, and other physiologic considerations ( eg, CMV, EBV status); (7) registration in an advanced donation program, 22 and; (8) altruistic motives, “helping the greater good,” by creating more transplants via KPD. Confidence in KPD is growing—allowing for mainstream KLYs optimization to take place—and is reinforced by early results showing favorable outcomes with shipped living donor kidneys.…”
Section: Discussionmentioning
confidence: 99%
“…4 All participants should consider options that may translate into greater graft longevity or KLYs. There are at least 8 reasons why a participant (either compatible or incompatible) may choose to enroll in KPD with the goal of “trading-up” for a better outcome through donor optimization (measured in KLYs) among other reasons, listed as follows: (1) transplants may last longer (ie, higher expected KLYs) with better donor selection; (2) recipients may require less immunosuppression with better matching, and therefore experience less side effects from medication; (3) recipients may experience less morbidity/mortality by seeking a better match, especially in cases where aggressive desensitization can be avoided entirely 16-18 ; (4) recipients will be easier to transplant in the future (either with a living, or deceased donor) should they require it, because they will be sensitized to fewer antigens (DSA) 20 ; (5) participants help others while at the same time helping the intended recipient who faces the possibility of a repeat transplant if a graft fails—this not only by offloading competition on the waitlist by enabling more transplants per unit time, but also by facilitating more difficult to accomplish transplants in sensitized cohorts of recipients of which the intended recipient may become a member (by developing DSA) should they require a repeat transplant in the future, these concepts being supported by the mathematics driving KPD 3,4,20,21 (6) donor-recipient anatomic, and other physiologic considerations ( eg, CMV, EBV status); (7) registration in an advanced donation program, 22 and; (8) altruistic motives, “helping the greater good,” by creating more transplants via KPD. Confidence in KPD is growing—allowing for mainstream KLYs optimization to take place—and is reinforced by early results showing favorable outcomes with shipped living donor kidneys.…”
Section: Discussionmentioning
confidence: 99%
“…Kidney paired donation (KPD) is an effective means of overcoming immunological barriers to living donor transplantation (1–12). The competition engendered by various paired donation registries has led to unique strategies and innovations (13).…”
Section: Introductionmentioning
confidence: 99%
“…These chains may be simultaneous where all of the transplants occur over a period of 1 to a few days or nonsimultaneous extended chains. (4)(5)(6) In the nonsimultaneous setting, bridge donors may wait days to months until additional pairs are added to the chain. In either scenario, most chains are ultimately ended with donation of a living donor kidney to a recipient on the deceased donor list.…”
Section: Kidney Paired Exchange Backgroundmentioning
confidence: 99%